PRESBYOPIA
Clinical trials for PRESBYOPIA explained in plain language.
Never miss a new study
Get alerted when new PRESBYOPIA trials appear
Sign up with your email to follow new studies for PRESBYOPIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New lens implant aims to sharpen vision for cataract patients
Disease control OngoingThis study tests a special lens implant that corrects cataracts, presbyopia (need for reading glasses), and astigmatism (blurry vision from an irregularly shaped cornea). The goal is to see if this lens stays stable in the eye and provides good vision at all distances. About 100 …
Matched conditions: PRESBYOPIA
Phase: NA • Sponsor: Beaver-Visitec International, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New lens implants promise clear vision at all distances after cataract surgery
Disease control OngoingThis study tests two types of advanced lens implants (IOLs) for people having cataract surgery in both eyes. The lenses are designed to help see clearly at far, arm's length, and near distances. Researchers will check safety and how well the lenses work in 110 participants over t…
Matched conditions: PRESBYOPIA
Phase: NA • Sponsor: Alcon Research • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Free glasses may help seniors bank from home
Symptom relief OngoingThis study gives free reading glasses and basic smartphone training to older adults in Bangladesh who receive government benefits. The goal is to see if better vision helps them use mobile banking more often and independently. About 571 people aged 48 to 70 with presbyopia (age-r…
Matched conditions: PRESBYOPIA
Phase: NA • Sponsor: Queen's University, Belfast • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
New lens tech aims to sharpen sight after cataracts
Symptom relief OngoingThis study tests new versions of Clareon Vivity Pro intraocular lenses (IOLs) to see if they improve vision better than current lenses. About 231 adults with cataracts in both eyes will receive one new lens and one current lens to compare results. The main goal is to measure how …
Matched conditions: PRESBYOPIA
Phase: NA • Sponsor: Alcon Research • Aim: Symptom relief
Last updated Aug 08, 2026 00:03 UTC
-
A tiny corneal pocket may restore Close-Up vision — no glasses needed
Symptom relief ENROLLING_BY_INVITATIONThis trial tests whether creating a small pocket inside the cornea using the SMILE module can improve near vision in people with presbyopia who want to avoid glasses. The procedure aims to increase the eye's ability to focus on close objects. Researchers are measuring how much ne…
Matched conditions: PRESBYOPIA
Phase: NA • Sponsor: Eye Hospital Pristina Kosovo • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
Could a tiny corneal implant replace reading glasses?
Symptom relief OngoingThis study tests a new device called CorVision, a tiny lens made from collagen that is placed inside the cornea to improve near vision in people with presbyopia (age-related difficulty seeing up close). 110 adults aged 40-65 will receive the implant in one eye through a minimally…
Matched conditions: PRESBYOPIA
Phase: NA • Sponsor: LinkoCare Life Sciences AB • Aim: Symptom relief
Last updated Jun 26, 2026 12:33 UTC
-
Which reading glasses give the best view? new study puts three lens designs to the test
Knowledge-focused OngoingThis study compares three types of progressive lenses to see which provides the widest clear vision at distances from 4 meters down to 25 centimeters. About 26 presbyopic participants will test each lens in a random, double-blind order. The goal is to help eye doctors choose the …
Matched conditions: PRESBYOPIA
Phase: NA • Sponsor: University of Seville • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Eye lens implant safety study pulled before starting
Knowledge-focused TerminatedThis study was designed to check the long-term safety and performance of AcrySof IQ Vivity lens implants in people who had them in both eyes for 3 to 5 years. It was a real-world observation, not a treatment test. However, the study was withdrawn before enrolling any participants…
Matched conditions: PRESBYOPIA
Phase: NA • Sponsor: Alcon Research • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:27 UTC